Takayuki Shimose

Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations

Eiji Iwama, Kazuko Sakai, Koichi Azuma et al. · Annals of Oncology · 2016 · 93 citations

Medicine, Molecular Genetics, Oncology +17

Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401)

Eiji Iwama, Yasushi Goto, Haruyasu Murakami et al. · Journal of Thoracic Oncology · 2017 · 54 citations

Medicine, Oncology, Pharmacology +14

Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing

Eiji Iwama, Kazuko Sakai, Koichi Azuma et al. · Cancer Science · 2018 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A)

Shun Sasaki, Eiji Oki, Hiroshi Saeki et al. · International Journal of Clinical Oncology · 2019 · 39 citations

Medicine, Oncology, Chemotherapy +13

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt)

Koji Nagafuji, Itaru Matsumura, Takayuki Shimose et al. · International Journal of Hematology · 2019 · 33 citations

Medicine, Oncology, Pharmacology +7